Measles-Mumps-Rubella Vaccine and COVID-19 Relationship
Copyright policy )Measles-Mumps-Rubella Vaccine and COVID-19 Relationship
I have read the article by Fidel and Noverr with great interest (1). As told in the article, could measles-mumps-rubella (MMR) vaccine really be a “low-risk–high-reward” measure in COVID-19? However, I have several concerns about their opinion/hypothesis posed in their article (1). First, global ecological/epidemiological data might have suggested a correlation between MMR vaccination rate and decreased COVID-19 mortality (1). Some researchers disagreed with this conclusion for the live vaccines including MMR other than BCG (2). Some countries like Iran and Latin American countries, e.g., Chile, Argentina, and Ecuador, …
- Sakarya University Turkey
Inflammation, SARS-CoV-2, Pneumonia, Viral, COVID-19, Microbiology, Betacoronavirus, Virology, Humans, Coronavirus Infections, Letter to the Editor, Pandemics, Measles-Mumps-Rubella Vaccine, Measles
Inflammation, SARS-CoV-2, Pneumonia, Viral, COVID-19, Microbiology, Betacoronavirus, Virology, Humans, Coronavirus Infections, Letter to the Editor, Pandemics, Measles-Mumps-Rubella Vaccine, Measles
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).9 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!